![Dalia Megiddo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dalia Megiddo
Founder at Nasus Pharma Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mutya Harsch | F | 50 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
Udi Gilboa | M | 57 |
Nasus Pharma Ltd.
![]() Nasus Pharma Ltd. Medical SpecialtiesHealth Technology Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo. | - |
Ronnie Hershmann | M | - |
Nasus Pharma Ltd.
![]() Nasus Pharma Ltd. Medical SpecialtiesHealth Technology Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo. | - |
Dov Amar | M | - |
Nasus Pharma Ltd.
![]() Nasus Pharma Ltd. Medical SpecialtiesHealth Technology Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Meir Eini | M | 69 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 14 years |
Dov Tamarkin | M | 68 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 15 years |
Darrell S. Rigel | M | 73 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 4 years |
Anthony Bruno | M | 68 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 2 years |
Limor Sandach | F | - |
7-Health Ventures Ltd.
![]() 7-Health Ventures Ltd. Investment ManagersFinance 7-Health Ventures Ltd (7 Health Ventures) is a venture capital firm founded in 2007 by Dalia Megiddo. The firm is headquartered in Herzliya Pituach, Israel. | 2 years |
Zaidman Yakov Amir | M | 55 |
7-Health Ventures Ltd.
![]() 7-Health Ventures Ltd. Investment ManagersFinance 7-Health Ventures Ltd (7 Health Ventures) is a venture capital firm founded in 2007 by Dalia Megiddo. The firm is headquartered in Herzliya Pituach, Israel. | 3 years |
Iain Stuart | M | 51 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 4 years |
Matthew Wiley | M | 52 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 2 years |
Ray Steitz | M | - |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
Deepa Desai | M | - |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
Sharon Barbari | F | 70 |
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 15 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dalia Megiddo
- Personal Network